Unlike previous studies conducted on the whole spectrum of dystrophinopathies [9], [10], we stringently included patients without any residual dystrophin at Western blot. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.